幸运飞艇人工计划appin 2019, charles r. broderick, am ’05, made gifts totaling $9m to mit and harvard to study the effects of cannabis on the brain and behavior. his gifts represent the largest philanthropic investment toward independent research on the science of cannabinoids on record.
幸运飞艇人工计划appthe broderick fund for phytocannabinoid research is supporting research in several brain research labs across mit and harvard, including that of professors john gabrieli, phd, and bruce bean, phd. in this forum, broderick, gabrieli, and bean will discuss the need for fundamental research on cannabis to inform evidence-based clinical guidelines and societal policies and some of the current cannabis research projects underway.
About Charles R. Broderick, AM ’05
Charles R. Broderick is the founder of Uji Capital LLC, a family office focused on quantitative opportunities in global equity capital markets. Identifying the growth of the Canadian legal cannabis market as a strategic investment opportunity, Broderick took equity positions in Tweed Marijuana Inc. and Aphria Inc., which have since grown into two of North America’s most successful cannabis companies. Subsequently, Broderick served as a board member for Tokyo Smoke, a cannabis brand portfolio, which merged in 2017 to create Hiku Brands, where he served as chairman. Broderick earned his SB and SM in computer science from MIT and his MA in East Asian Studies from Harvard.
John Gabrieli is the director of the Athinoula A. Martinos Imaging Center at the McGovern Institute at MIT. He is an investigator at the McGovern Institute, with faculty appointments in Brain and Cognitive Sciences and the Institute for Medical Engineering & Science, where he holds the Grover Hermann Professorship. Prior to joining MIT in 2005, he spent 14 years at Stanford University. He earned his PhD in Behavioral Neuroscience from MIT.
幸运飞艇人工计划app Bruce Bean is Robert Winthrop Professor of Neurobiology at Harvard Medical School. Bean graduated from Harvard College, received a PhD in Biophysics from the University of Rochester, did postdoctoral work with Richard W. Tsien at the Yale School of Medicine, and has previously held faculty positions at the University of Iowa and the Vollum Institute of Oregon Health Sciences University. His research interests are in the electrophysiology of neurons and muscle and in using ion channels to develop new therapeutic treatments.